Circulating Tumor DNA Analysis of the Phase III VOYAGER Trial: KIT Mutational Landscape and Outcomes in Patients With Advanced Gastrointestinal Stromal Tumor Treated With Avapritinib or Regorafenib☆
c-kit
Pyrosequencing Evaluation of Widely Available Bisulfite Conversion Methods: Considerations for Application
Efficacy and Safety of Nilotinib in Patients With KIT-Mutated Metastatic or Inoperable Melanoma: Final Results From the Global, Single-Arm, Phase II TEAM Trial
Prognostic Value of KIT/PDGFRA Mutations in Gastrointestinal Stromal Tumours (GIST): Polish Clinical GIST Registry Experience
C-Kit
C-KIT Expression and Correlation With Chemotherapy Resistance in Ovarian Carcinoma: An Immunocytochemical Study
Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants
c‐KIT
Humanized C-Kit Antibody